Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 2 48-2, 2003, Pages

  Tfelt Hansen, J ^a   MacLeod, R J ^a   Chattopadhyay, N ^a   Yano, S ^a   Quinn, S ^a   Ren, X ^b   Terwilliger, E F ^b   Schwarz, P ^c   Brown, E M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

^c Mental Health Services CPH   (Denmark)

Author keywords

Dominant negative; G protein coupled receptor; Humoral hypercalcemia of malignancy; Leydig cells; Osteolysis; Stress activated protein kinase activator 1

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CALCIUM ION; CALCIUM SENSING RECEPTOR; DACTINOMYCIN; G PROTEIN COUPLED RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CLINICAL PATHWAY; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; LEYDIG CELL; MALE; NONHUMAN; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0042303745     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00489.2002     Document Type: Article

References (37)

1. Aklilu F, Gladu J, Goltzman D, and Rabbani SA. Role of mitogen-activated protein kinases in the induction of parathyroid hormone-related peptide. Cancer Res 60: 1753-1760, 2000.
2. Arthur JM, Lawrence MS, Payne CR, Rane MJ, and McLeish KR. The calcium-sensing receptor stimulates JNK in MDCK cells. Biochem Biophys Res Commun 275: 538-541, 2000.
3. Bai M, Pearce SH, Kifor O, Trivedi S, Stauffer UG, Thakker RV, Brown EM, and Steinmann B. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99: 88-96, 1997.
4. Bai M, Quinn S, Trivedi S, Kifor O, Pearce SHS, Pollak MR, Krapcho K, Hebert SC, and Brown EM. Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem 271: 19537-19545, 1996.
5. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, and Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686, 2001.
6. Brandt DW, Pandol SJ, and Deftos LJ. Calcium-stimulated parathyroid hormone-like protein secretion: potentiation through a protein kinase-C pathway. Endocrinology 128: 2999-3004, 1991.
7. Chattopadhyay N, Butters RR, and Brown EM. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Brain Res Mol Brain Res 87: 100-108, 2001.
8. Che Y, Yu YM, Han PL, and Lee JK. Delayed induction of p38 MAPKs in reactive astrocytes in the brain of mice after KA-induced seizure. Brain Res Mol Brain Res 94: 157-165, 2001.
9. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
10. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, and Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995.
11. Dudley DT, Pang L, Decker SJ, Bridges AJ, and Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92: 7686-7689, 1995.
12. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, and Martin TJ. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73: 1309-1315, 1991.
13. Hastings RH, Duong H, Burton DW, and Deftos LJ. Alveolar epithelial cells express and secrete parathyroid hormone-related protein. Am J Respir Cell Mol Biol 11: 701-706, 1994.
14. Hjalm G, MacLeod RJ, Kifor O, Chattopadhyay N, and Brown EM. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 276: 34880-34887, 2001.
15. Ho PD, Zechner DK, He H, Dillmann WH, Glembotski CC, and McDonough PM. The Raf-MEK-ERK cascade represents a common pathway for alteration of intracellular calcium by Ras and protein kinase C in cardiac myocytes. J Biol Chem 273: 21730-21735, 1998.
16. Hobson SA, McNeil SE, Lee F, and Rodland KD. Signal transduction mechanisms linking increased extracellular calcium to proliferation in ovarian surface epithelial cells. Exp Cell Res 258: 1-11, 2000.
17. Huang C, Handlogten ME, and Miller RT. Parallel activation of phosphatidylinositol 4-kinase and phospholipase C by the extracellular calcium-sensing receptor. J Biol Chem 277: 20293-20300, 2002.
18. Ju H, Nerurkar S, Sauermelch CF, Olzinski AR, Mirabile R, Zimmerman D, Lee JC, Adams J, Sisko J, Berova M, and Willette RN. Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury. J Pharmacol Exp Ther 301: 15-20, 2002.
19. Kakonen SM, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y, and Guise TA. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J Biol Chem 277: 24571-24578, 2002.
20. Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, Yao T, Kifor I, and Brown EM. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 280: F291-F302, 2001.
21. Kim DS, Kim SY, Chung JH, Kim KH, Eun HC, and Park KC. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal 14: 779-785, 2002.
22. Kobayashi N, Russell J, Lettieri D, and Sherwood LM. Regulation of protein kinase C by extracellular calcium in bovine parathyroid cells. Proc Natl Acad Sci USA 85: 4857-4860, 1988.
23. MacLeod RJ, Chattopadhyay N, and Brown EM. PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab 284: E435-E442, 2003.
24. Marti A, Luo Z, Cunningham C, Ohta Y, Hartwig J, Stossel TP, Kyriakis JM, and Avruch J. Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-activation of SAPK in melanoma cells. J Biol Chem 272: 2620-2628, 1997.
25. Murphy LO, Smith S, Chen RH, Fingar DC, and Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4: 556-564, 2002.
26. Nebreda AR and Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem Sci 25: 257-260, 2000.
27. Rabbani SA, Gladu J, Liu B, and Goltzman D. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide. Endocrinology 136: 5416-5422, 1995.
28. Saklatvala J, Rawlinson L, Waller RJ, Sarsfield S, Lee JC, Morton LF, Barnes MJ, and Farndale RW. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 271: 6586-6589, 1996.
29. Samarakoon R and Higgins PJ. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks. J Cell Sci 115: 3093-3103, 2002.
30. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, and Brown EM. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy. Biochem Biophys Res Commun 269: 427-432, 2000.
31. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, and Brown EM. Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 281: E1267-E1274, 2001.
32. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, and Brown EM. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 141: 4357-4364, 2000.
33. Schramek H. MAP kinases: from intracellular signals to physiology and disease. News Physiol Sci 17: 62-67, 2002.
34. Sitaraman SV, Merlin D, Wang L, Wong M, Gewirtz AT, Si-Tahar M, and Madara JL. Neutrophil-epithelial crosstalk at the intestinal luminal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest 107: 861-869, 2001.
35. Tfelt-Hansen J, Yano S, Brown EM, and Chattopadhyay N. The role of the calcium-sensing receptor in human pathophysiology. Curr Med Chem 2: 175-193, 2002.
36. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, and Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991.
37. Wu P, Philips MI, Bui J, and Terwilliger EF. Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J Virol 72: 5919-5926, 1998.